EN
IT
DE
JP
CN
ES
Choose a language
EN
IT
DE
JP
CN
ES
For more than 70 years, we have been committed to provide integrated solutions for pharma and healthcare, leveraging on constant investment and the acquisition of skills in new technologies. A rich, international heritage has brought us to become a global player in the pharma industry.
SCROLL TO START TIMELINE
Stevanato Group Foundation
Stevanato Group’s history has its roots in the foundation of Soffieria Stella in Zelarino, near Venice specialized in the production of glass bottles. In 1959, the glassware factory moves to Piombino Dese, closing a few years later.
OMPI is established
Ompi, the specialist in glass primary packaging is born in its current location in Piombino Dese, Padua. A few years later, leveraging on its in-house technological competencies brought in by Spami, dedicated to the production of glass converting lines, the company will develop a unique expertise in the production of high-quality glass primary packaging.
SPAMI Foundation
Spami is established in Piombino Dese. It is a company specialized in the design and production of high-speed, high-precision glass forming lines to obtain high-quality containers from tubing.
ALFAMATIC Acquisition
Stevanato Group acquires a manufacturing plant for glass containers in Latina, Italy.
MEDICAL GLASS Acquisition
Medical Glass, a glass container manufacturing plant based in Slovakia, joins Stevanato Group and marks the first step of the internationalization process.
Start-up of the manufacturing of sterilized glass containers: EZ-fill®
A new department dedicated to the production of EZ-fill® ready-to-fill, sterilized syringes, opens in Piombino Dese. It is soon followed by the opening of dedicated production departments for ready-to-use vials and cartridges.
Optrel acquisition
The Group acquires Optrel, an Italian company specialized in the manufacture of inspection machines for glass containers for pharmaceutical industry.
Greenfield in Mexico
Stevanato Group opens its first greenfield site in Monterrey, Mexico.
Greenfield in China
A new commercial office opens in China in 2012, and a new plant manufacturing glass container in Zhangjiagang is inaugurated a few years later.
InnoScan acquisition
Stevanato Group acquires InnoScan, a Danish company who specializes in the production of high-speed inspection systems for complex drugs.
SG Lab Foundation
The Group starts up its internal laboratory dedicated to perform analytical services to study the interactions of drug and containers.
SVM acquisition
The Danish company SVM, specialized in assembly and packaging equipment of medical devices is acquired.
Balda acquisition
Stevanato Group acquires Balda, a company with manufacturing facilities in Germany and California, specialized in plastic development and manufacturing for diagnostic consumables, drug delivery systems and medical components.
Greenfield in Brazil
A new glass container manufacturing plant, the third greenfield project of the Group, is opened in Sete Lagoas, Brazil.
Opening the Commercial office in Japan
A commercial office to be closer to the local customers is opened in Nagoya, Japan.
Expanding production capacity for syringes
The Group expand its premises in Piombino Dese, with a new production plant on an area of 17,000 sq meters for the manufacturing of syringes.
US TEC Opening
SG US Technology Excellence Center will open in Boston, Massachusetts to provide Biopharma companies with integrated analytical services and effective project management for drug development and commercialization.
A history of continuous improvement, growth and innovation: Stevanato Group’s global presence leverages on competencies, skills and technologies acquired over its more than 70 years of history. Watch the historical milestones of our Group on our Timeline video.